PDE5A and endothelial dysfunction: Therefore, the present data revealing the beneficial effects of sildenafil support the concept that this inhibitor of PDE5 could be included in the hallmark of anti-hypertensive agents currently available, especially as an additional drug in patients with resistant hypertension despite the use of three or more drugs and in patients with endothelial dysfunction and kidney disease.